Modification of second cancer risk after malignant melanoma by parental history of cancer

British Journal of Cancer

Volumn 99, Issue 3, 2008, Pages 536-538

  Zhang, H ^a   Bermejo, J Lorenzo ^a   Sundquist, J ^b   Hemminki, K ^a,b  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Familial risk; Genetic susceptibility; Melanoma; Second cancer

Indexed keywords

ANAMNESIS; ARTICLE; CANCER INCIDENCE; CANCER RISK; FAMILY HISTORY; GENETIC SUSCEPTIBILITY; HUMAN; MAJOR CLINICAL STUDY; MELANOMA; PARENT; PRIORITY JOURNAL; RISK MANAGEMENT; SECOND CANCER;

ADULT; AGED; COHORT STUDIES; HUMANS; MEDICAL HISTORY TAKING; MELANOMA; MIDDLE AGED; NEOPLASMS, SECOND PRIMARY; PARENTS; RETROSPECTIVE STUDIES; RISK FACTORS; SKIN NEOPLASMS; SWEDEN;

EID: 48349120795     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6604489     Document Type: Article

References (18)

1. Bhatia S, Estrada-Batres L, Maryon T, Bogue M, Chu D (1999) Second primary tumors in patients with cutaneous malignant melanoma. Cancer 86: 2014-2020
2. Box NF, Duffy DL, Irving RE, Russell A, Chen W, Griffyths LR, Parsons PG, Green AC, Sturm RA (2001) Melanocortin-1 receptor genotype is a risk factor for basal and squamous cell carcinoma. J Invest Dermatol 116: 224-229
3. Brown VL, Harwood CV, Crook T, Cronin JG, Kelsell DR, Proby CM (2004) p16INK4a and p14ARF tumor suppressor genes are commonly inactivated in cutaneous squamous cell carcinoma. J Invest Dermatol 122: 1284-1292
4. Debniak T, Cybulski C, Górski B, Huzarski T, Byrski T, Gronwald J, Jakubowska A, Kowalska E, Oszurek O, Narod SA, Lubiński J (2007) CDKN2A-positive breast cancers in young women from Poland. Breast Cancer Res Treat 103: 355-359
5. de Vries E, Coebergh JW (2004) Cutaneous malignant melanoma in Europe. Eur J Cancer 40: 2355-2366
6. Ebbesen P (1981) Enhanced lymphoma incidence in BALB/c mice after ultraviolet treatment. J Natl Cancer Inst 67: 1077-1078
7. Figl A, Thirumaran RK, Ugurel S, Gast A, Hemminki K, Kumar R, Schadendorf D (2007) Multiple melanomas after treatment for Hodgkin lymphoma in a non-Dutch p16-Leiden mutation carrier with 2 MC1R high-risk variants. Arch Dermatol 143: 495-499
8. Goggins WB, Tsao H (2003) A population-based analysis of risk factors for a second primary cutaneous melanoma among melanoma Survivors. Cancer 97: 639-643
9. Hemminki K, Vaittinen P (1997) Interaction of breast cancer and melanoma genotypes. Lancet 350: 931-932
10. Hemminki K, Dong C (2000) Subsequent cancers after in situ and invasive squamous cell carcinoma of the skin. Arch Dermatol 136: 647-651
11. Hemminki K, Jiang Y, Steineck G (2003) Skin cancer and non-Hodgkin's lymphoma as second malignancies, markers of impaired immune function? Eur J Cancer 39: 223-229
12. Hemminki K, Granström C, Sundquist J, Lorenzo Bermejo J (2006) The updated Swedish family-cancer database used to assess familial risks of prostate cancer during rapidly increasing incidence. Heredit Cancer in Clin Pract 4: 186-192
13. Miller AJ, Mihm Jr MC (2006) Melanoma. N Engl J Med 355: 51-65
14. Palmer JS, Duffy DL, Box NF, Aitken JF, O'Gorman LE, Green AC, Hayward NK, Martin NG, Sturm RA (2000) Melanocortin-1 receptor polymorphisms and risk of melanoma: is the association explained solely by pigmentation phenotype? Am J Hum Genet 66: 176-186
15. Romedahl CA, Donawho C, Fidler IJ, Kripke ML (1988) Effect of ultraviolet-B radiation on the in vivo growth of murine melanoma cells. Cancer Res 48: 4007-4010
16. Schmid-Wendtner M-H, Baumert J, Wendtner C-M, Plewig G, Volkenandt M (2001) Risk of second primary malignancies in patients with cutaneous melanoma. Br J Dermatol 145: 981-985
17. Sinha S, Chunder N, Mukherjee N, Alam N, Roy A, Roychoudhury S, Kumar Panda C (2008) Frequent deletion and methylation in SH3GL2 and CDKN2A loci are associated with early- and late-onset breast carcinoma. Ann Surg Oncol 15(4): 1070-1080
18. Soufir N, Molès JP, Vilmer C, Moch C, Verola O, Rivet J, Tesniere A, Dubertret L, Basset-Seguin N (1999) P16 UV mutations in human skin epithelial tumors. Oncogene 18: 5477-5481